Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

JCXH-211

2 clinical trials

2 indications

Indication
Skin Tumor
Indication
Malignant Solid Tumor
Clinical trial
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211 Intratumoral Injection in Patients With Malignant Solid Tumors
Status: Recruiting, Estimated PCD: 2025-07-24
Clinical trial
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211 Intratumoral Injection in Patients With Malignant Solid Tumors
Status: Active (not recruiting), Estimated PCD: 2024-03-01